WhenFriday, Apr 6, 2018
Description2018-04-06 The expected action date by the FDA under the Prescription Drug User Fee Act (PDUFA) is April 6, 2018. https://www.globenewswire.com/news-release/2017/10/18/1149139/0/en/Pacira-Pharmaceuticals-Announces-FDA-Acceptance-of-sNDA-for-EXPAREL-as-a-Nerve-Block-to-Produce-Regional-Analgesia.html
edr ose
sh ut up